(Q57316359)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

editorial

0 references

title

Omecamtiv mecarbil: a promising new drug in systolic heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

systolic heart failure

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Matthijs F L Meijs

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Pieter A Doevendans

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

28 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

232-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Clinical practice. Systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Cardiac inotropes: current agents and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Mechanisms and use of calcium-sensitizing agents in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Cardiac myosin activation: a potential therapeutic approach for systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR178

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFR178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22210833%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference